MARKETS / COMPANIES / ECONOMYRSS edition ↗
Exchange Dispatch
Economy

PSBs, pharma and defence: HDFC Securities CEO names Samvat 2083’s dark horses

Benchmarks Nifty25,030.35493.75FEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return9.96 % Invest NowFEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return19.25 % Invest NowEnter search…

PSBs, pharma and defence: HDFC Securities CEO names Samvat 2083’s dark horses
Benchmarks Nifty25,030.35493.75FEATURED FUNDS★★★★★UTI Aggressive Hybrid Fund Regular Plan-Growth5Y Return9.96 % Invest NowFEATURED FUNDS★★★★★Motilal Oswal Midcap Fund Direct-Growth5Y Return19.25 % Invest NowEnter search text:
    The Economic Times daily newspaper is available online now. Read Today's Paper PSBs, pharma and defence: HDFC Securities CEO names Samvat 2083’s dark horsesBy Nikhil Agarwal, ETMarkets.comLast Updated: Nov 08, 2026, 01:09:00 PM ISTSynopsis

    HDFC Securities MD and CEO Dhiraj Relli identifies public sector banks, pharmaceuticals and defence as potential outperformers in Samvat 2083. He favours largecaps for valuation comfort, highlights selective stock opportunities and urges investors to prioritise earnings visibility and disciplined asset allocation.

    Listen to this article in summarized format

    Loading...×Public sector banks, pharmaceutical companies and defence stocks could emerge as the dark horses of Samvat 2083, according to Dhiraj Relli, MD & CEO of HDFC Securities, who sees stronger earnings visibility in these pockets despite elevated market volatility.

    Relli remains relatively more constructive on largecaps after the recent correction, arguing that they offer greater comfort on valuations and a more resilient risk-adjusted baseline than the mid- and smallcap segments. Edited excerpts from a chat:

    As Samvat 2083 begins, the sharp divergence between the performance of largecaps and small/midcaps have attracted attention. Some think that largecaps have enough value after correction while others argue that SMID space has higher growth and winners of the future. Which side are you and why?

    While large-cap indices offer stability and institutional liquidity, the Nifty Midcap and Smallcap indices have historically delivered sharper rallies and also face significant corrections during broader economic expansions, occasionally outperforming large caps significantly at peaks and during systematic investment plan (SIP) inflows.

    We note that many midcaps and smallcaps capture high-growth themes effectively; the segment also contains high valuation dispersion and cyclical vulnerabilities. Large caps continue to provide a more resilient risk-adjusted baseline during market corrections, meaning the broader market story depends heavily on individual stock selection rather than the index.

    Live Events


        The earnings environment in India remains quite constructive given the pickup in inflation and nominal growth. Nifty earnings are expected to see a high-teens CAGR over FY26-28E. Largecaps offer reasonable comfort given their current valuations relative to historical trends. On the other hand, aggregate valuations remain much more demanding in mid and smallcaps, though their earnings momentum seems strong. One needs to be extremely selective and watchful in smallcaps, especially as volatility remains high. Largecaps appear relatively better positioned through a risk-management lens.

        After two years of muted market returns, are we going through a normal earnings-led consolidation or an early warning that India’s structural growth premium is being re-rated?

        The more balanced interpretation is an earnings catch-up phase alongside a reassessment of valuations—not yet a rejection of India’s structural growth story. The distinction matters: a strong economy does not automatically deliver strong equity returns when starting valuations already discount substantial future growth.

        India’s valuation premium has clearly compressed. MSCI India’s forward price-to-earnings multiple was around 18.5 times in late October, down from 24.54 times at its September 2024 peak, though it remained more expensive than emerging-market peers. This suggests investors are reassessing the price paid for growth, rather than necessarily abandoning the growth opportunity itself.

        India’s longer-term investment case continues to draw support from domestic demand, infrastructure investment, reforms and demographics. The key test is the breadth and durability of the earnings recovery. Sustained sales growth, stable margins and a broader revival in private investment would support the consolidation interpretation. Repeated earnings disappointments, weaker returns on capital or a prolonged failure of investment to respond would strengthen the case for a more structural reassessment.

        IT stocks have rebounded after months of underperformance. Is this the beginning of a sustainable earnings cycle driven by AI and technology spending, or simply a valuation-led bounce?

        The recent rebound in IT stocks reflects a mix of global sector rotation and value-driven buying, rather than the start of a strong, sustained earnings uptrend. The NSE IT Index rose about 17%, even as the Nifty 50 declined around 4% over the last month.

        By late September, trailing P/E multiples for major IT exporters had fallen to near-historical lows of roughly 13x, resulting in a sizeable valuation discount of about 33% relative to the broader market.

        A key trigger was the global shift in investor preference. Concerns over elevated valuations and slower return profiles in AI‑focused hardware, semiconductor, and hyperscaler companies led investors to book profits and shift capital toward relatively cheaper, defensive segments such as traditional IT services.

        Supportive quarterly results from select firms also contributed. For instance, HCL Tech’s sharp rise in advanced AI-related revenue indicated that companies executing well on data engineering and AI-led projects are seeing tangible demand, encouraging value buying across the sector.

        Despite the recent improvement, the overall demand environment remains subdued, and a durable recovery has not yet taken shape. Growth is expected to improve gradually in FY28E, but selectivity remains important, with preference for companies offering better earnings visibility. Currently, the NSE IT Index trades at 18.1x one-year forward consensus earnings, versus a five-year average of 24x and a pre-pandemic five-year average of 17x.

        Which sector or investment theme could emerge as the dark horse of Samvat 2083, and what underappreciated fundamental trigger could unlock that opportunity?

        Preferred sectors/themes

        Finance

        PSBs have benefited from relatively better balance-sheet positioning, while some private banks continue to manage tighter deposit accretion. Asset quality continued to improve, with limited fresh slippages and broadly stable stress indicators across the formal banking system.

        Looking ahead, credit demand is expected to remain healthy, and PSBs may outperform private banks given their lower credit-to-deposit ratios. NIM pressure is likely to ease gradually, especially as repo rate cuts appear unlikely in the near term.

        Picks: Axis Bank, ICICI Bank, City Union Bank, UCO Bank

        Pharma

        For the US piece, overall business is dependent on company-specific launches; given lower shortages, US price erosion is not expected to come down further.

        The domestic piece of the business continues to grow at a healthy pace for large players. Indian pharma companies have been investing heavily in R&D and that should drive US business growth on the back of niche launches.

        We are positive on players like Ipca Labs, Sun Pharma, Emcure, Eris Life and Concord Biotech, where the earnings trajectory is strong for the medium to long term.

        We note that CDMO stocks have seen a sharp run-up in the last few months; most of the players continue to report strong numbers and given good earnings visibility in the medium to long term, we remain positive on stocks like Anthem Biosciences and Sai Lifesciences.

        Defence/Aerospace

        Ongoing geopolitical tensions have reshaped global supply chains and exposed vulnerabilities in military procurement, driving rapid expansion in indigenous manufacturing across aerospace, missiles, naval systems, armoured platforms, electronics, and ammunition.

        Defence & Aerospace companies continue to report strong results in the last few quarters. Although the stocks have seen significant run up, given that they have multi-year revenue visibility, we continue to remain positive on the sector. For most of the players, additionally, large export opportunities would also improve prospects.

        Picks: BEL, Bharat Forge

        For an investor with ₹10 lakh and a five-year horizon, how would you allocate capital across largecaps, midcaps, smallcaps, debt, gold and international equities and what would make you change that allocation?

        For an investor with ₹10 lakh and a five-year horizon, start with risk capacity and the purpose of the money—not a standard allocation. A conservative approach would emphasise high-quality debt, with limited equity exposure centred on largecaps. A balanced approach would combine debt with largecaps and selective midcaps, while a higher-risk approach could accommodate greater midcap and smallcap exposure. Gold and diversified international equities can add diversification, but neither should be treated as risk-free. These are broad portfolio frameworks, not individual recommendations.

        Geopolitical developments would influence the balance. An escalation that keeps oil prices elevated, and inflation persistent would strengthen the case for liquidity, high-quality short-duration debt and greater caution towards smaller companies. Gold could remain a diversifier, but not an assured hedge: inflation shocks can pressure both bonds and gold. Conversely, de-escalation, lower energy costs, and easier financial conditions could support a gradual increase in equity exposure, where valuations remain reasonable. International equities should provide geographic diversification rather than represent a blanket bet that overseas markets will withstand geopolitical stress.

        Domestically, a broad-based earnings recovery, stronger private capex and reasonable valuations would support selectively increasing equity exposure. Persistent earnings downgrades, stretched valuations, or deteriorating credit conditions would favour a more defensive mix. The governing principle should be discipline: changes should reflect sustained shifts in fundamentals or the investor’s circumstances, rather than headlines, with capital preservation becoming more important as the five-year goal approaches.

        Gold now occupies a larger place in many portfolios. Should investors continue adding to it, hold their existing allocation or rebalance toward equities?

        For a long-term Indian portfolio, a practical allocation is 10% gold and 5% silver, or about 15% in precious metals overall, with gold remaining the core holding. Investors already at this level should generally avoid adding more and instead rebalance excess metal exposure into diversified equity funds.

        The key is to rebalance to a predetermined target, not short-term price views. If equities have corrected and gold has appreciated, shifting some gold profits back into equities can restore the intended risk-return balance; if gold has also corrected, it can be used to top up toward—not beyond—the strategic target.

        So, keep gold as a portfolio diversifier, but don't let it become an outsized bet. Investors underweight gold can add gradually toward a 5–10% target; those already at 10–15% should hold; and those materially above that range should consider rebalancing the excess toward quality equities.

        What is the one investment mistake investors should avoid in Samvat 2083 and the one opportunity they should not miss?

        Mistake to avoid

        The biggest risk is buying stocks simply because they have fallen sharply or because a theme is popular, without assessing valuation, earnings visibility and balance-sheet strength. After a difficult Samvat 2082, returns in the coming year will likely depend more on stock selection, valuation discipline, and earnings delivery than on broad liquidity-driven rallies. Even strong companies can deliver poor returns if bought at excessive valuations.

        Opportunity not to miss

        The opportunity investors should not miss is the chance to build or add to a portfolio of fundamentally strong companies through a staggered approach. Use any sharp correction to accumulate quality businesses at more reasonable valuations, rather than trying to time the market bottom. For most investors, the practical way to capture this is to step up SIPs or use STPs, rather than waiting for sentiment to improve.

        What's the one investing lesson that the last 2 years have taught us?

        Discipline beats prediction — and sticking to your asset allocation is the ultimate wealth-building habit. Quality earnings triumphed over short-term valuation jitters.
        Add as a Reliable and Trusted News Source Add Now!
        (You can now subscribe to our ETMarkets WhatsApp channel)
        Read More News onSamvat 2083 investment strategyDhiraj RelliHDFC Securitiesbest stocks for Samvat 2083PSU bank stockspharmaceutical stocks Indiadefence stocks Indialargecap versus smallcap stocksstock market outlook 2026investment opportunities India

        (What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

        Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

        ...moreless
        (You can now subscribe to our ETMarkets WhatsApp channel)
        Read More News onSamvat 2083 investment strategyDhiraj RelliHDFC Securitiesbest stocks for Samvat 2083PSU bank stockspharmaceutical stocks Indiadefence stocks Indialargecap versus smallcap stocksstock market outlook 2026investment opportunities India

        (What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

        Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

        ...morelessPrime ExclusivesInvestment IdeasStock Report PlusePaperWealth Edition
        • Seoul halts trading, Nifty has its best week since 2021: Money leaving the AI trade – will it land in India?

        • Junk bonds are cracking at the bottom. Will the noise get loud enough to make ‘junk bond’ a household term again?

        • PNG connections rise half a million, but how many use piped gas for cooking?

        • Some elections matter more than you know: No crop changed in the fields, yet sugar, coffee and soya got cheaper in a day

        • You can buy a walkie-talkie online. But can you legally use it?

        • KYB and KYC: Quick commerce, the Damani premium and what DMart must deliver – 3rd and concluding part

        • 1
        • 2
        • 3
        View all StoriesContinue reading with one of these options:Limited AccessFreeLogin to get access to some exclusive stories
        & personalised newslettersLogin NowUnlimited AccessStarting @ Rs120/monthGet access to exclusive stories, expert opinions &
        in-depth stock reportsSubscribe NowET

        Unlock Access to All Exclusives with ETPrime FREE TRIAL

        15 Days Free: Unlock All ETPrime Exclusives, Market Tools & ePapers

        Trial offer expiring in00 : 05 : 00

        I'd rather pay ₹2599 now

        Uh-oh! This is an exclusive story available for selected readers only.

        Worry not. You’re just a step away.

        Prime Account Detected!

        It seems like you're already an ETPrime member with

        Login using your ET Prime credentials to enjoy all member benefits

        Log out of your current logged-in account and log in again using your ET Prime credentials to enjoy all member benefits.

        Unlock ETPrime's Exclusive Stories Today!

        Big Price Drop! Flat 40% Off

        Student Only OfferAlready a Member? Sign In nowAlready a Member? Sign In nowAlready a Member? Sign In now

        Offer Exclusively For You

        Save up to Rs. 700/-

        ON ET PRIME MEMBERSHIP

        Avail Offer

        Offer Exclusively For You

        Get 1 Year Free

        With 1 and 2-Year ET prime membership

        Avail Offer

        Offer Exclusively For You

        Get 1 Year Free

        With 1 and 2-Year ET prime membership

        Avail Offer

        Offer Exclusively For You

        Get Flat 40% Off

        Then ₹ 1749 for 1 year

        Avail Offer

        Offer Exclusively For You

        ET Prime at ₹ 49 for 1 month

        Then ₹ 1749 for 1 year

        Avail Offer

        Special Offer

        Get flat 40% off on ETPrime

        Avail OfferAvail OfferClaim NowAlready a Member? Sign In now

        Need Assistance?

        Connect with an ETPrime expert for personalized support and guidance

        +91 9484700004'; }); } if(listing) { var h3 = "You tried reading " + listArr.length + " locked stories in the past " + threshold + " days.", h4 = "Become an ET Prime member and don't miss out on these exclusive stories."; var html = '

        ' + h3 + '

        ' + h4 + '

          ' + listing + '
        '; $('#paidSCWidget').html(html); var callback = $('#paidSCWidget').attr('data-callback'); if(callback && window[callback]) { window[callback](); } customDimension.dimension72 += ' | Shown SYFT no Trial_With Missed Paywalled Articles Collection'; } else { _processNormal() } } }); } else { _processNormal(); } } catch (e) { _processNormal(); } }, function () { _processNormal(); }); //console.log('storyCollectionLoad', $); }

        What’s Included with

        ETPrime Membership

        1Exclusive Insights That Matter

        Uncover the truth with our investigative stories

        Make strategic moves using the real-world case studies

        Read industry-specific stories to identify emerging trends

        Spot opportunities with
in-depth insights that matter

        • Trump temper on H-1B visas is forcing Indians to do these things to stay put in US

          What Adani’s US indictment means for India Inc’s overseas fundraising

        • Why veterans like Reliance, L&T are on acquisition spree? Aswath Damodaran has an answer.

          Will China’s dollar bond sale in Saudi Arabia trump the US in financial world?

        • Huawei launches its own OS to compete with Google and Apple. But can it win beyond China?

          The problem with lab grown diamonds

        • Why a falling rupee is a better option for the economy

          A list of top 20 momentum stocks that have delivered massive returns in one year

          2Invest Wisely With Smart Market Tools & Investment Ideas

          Alpha Trade

          Get daily trade ideas from SEBI-registered research analysts.

          Investment Ideas

          Grow your wealth with stock ideas & sectoral trends.

          Stock Reports Plus

          All-in-one stock research with Stock Score, peer comparison & key signals.

          BigBull Portfolio

          Get to know where the market bulls are investing to identify the right stocks.

          Stock Analyzer

          Check the score based on the company's fundamentals, solvency, growth, risk & ownership to decide the right stocks.

          Market Mood

          Analyze the market sentiments & identify the trend reversal for strategic decisions.

          Stock Talk Live at 9 AM Daily

          Ask your stock queries & get assured replies by ET appointed, SEBI registered experts.

          3Stay informed anytime, anywhere with ET ePaper

          ePaper - Print View

          Read the PDF version of ET newspaper. Download & access it offline anytime.

          ePaper - Digital View

          Read your daily newspaper in Digital View & get it delivered to your inbox everyday.

          Wealth Edition

          Manage your money efficiently with this weekly money management guide.

          TOI ePaper

          Read the PDF version of TOI newspaper. Download & access it offline anytime.

          Deep Explainers

          Explore the In-depth explanation of complex topics for everyday life decisions.

          Health+ Stories

          Get fitter with daily health insights committed to your well-being.

          Personal Finance+ Stories

          Manage your wealth better with in-depth insights & updates on finance.

          5Enjoy Complimentary Subscriptions From Top Brands

          Stream new documentaries from all across the world every day.

          Stories you might be interested in

            Source: Economic Times — Expert Views ↗

            Figures reflect the source report and its stated period. This article is for information and is not investment advice.